beta-lipotropin, gln(9)- has been researched along with 1,4,7-triazacyclononane in 1 studies
| Studies (beta-lipotropin, gln(9)-) | Trials (beta-lipotropin, gln(9)-) | Recent Studies (post-2010) (beta-lipotropin, gln(9)-) | Studies (1,4,7-triazacyclononane) | Trials (1,4,7-triazacyclononane) | Recent Studies (post-2010) (1,4,7-triazacyclononane) |
|---|---|---|---|---|---|
| 48 | 0 | 24 | 76 | 0 | 39 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dover, LG; Hunter, M; Tétard, D; Workman, DG | 1 |
1 other study(ies) available for beta-lipotropin, gln(9)- and 1,4,7-triazacyclononane
| Article | Year |
|---|---|
Synthesis of novel Iron(III) chelators based on triaza macrocycle backbone and 1-hydroxy-2(H)-pyridin-2-one coordinating groups and their evaluation as antimicrobial agents.
Topics: Anti-Infective Agents; Candida albicans; Drug Design; Enterobactin; Furans; Gram-Negative Bacteria; Gram-Positive Bacteria; Heterocyclic Compounds; Iron; Iron Chelating Agents; Microbial Sensitivity Tests; Oligopeptides; Polyamines; Pyridones; Solvents; Structure-Activity Relationship | 2016 |